Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by LannyMcdonaldon Nov 21, 2018 11:08am
96 Views
Post# 29004617

RE:More Of This Please !!!

RE:More Of This Please !!!

Thanks u2bob for finding the article.

 

If the pilot project is a success, Larente expects to be setting up Cara screening centres in hospitals and clinics across Quebec

 

 

 

If the pilot project is a success. We all know it will be, including Andre in the next paragraph. 

Once the pilot project is completed Larente expects to see Cara screening facilities in Quebec hospitals and just as a successful pilot project in Mexico led to a government contract, he expects the CHUM pilot project to result in a contract with the Quebec Ministry of Health.

Light years ahead of the competition

 

 

Dr. Reed Maclellan described the company’s technology as being “light years ahead of the competition. I was at a recent conference and nobody, not even Google can do what Cara can. Cara can detect macular degeneration. This is the only technology in the world that can do it. Diagnos is five years ahead of Google.”

Cara can detect macular degeneration.

This is the only technology in the world that can do it.

When this snow ball starts rolling in the province of Quebec, it won’t stop rolling until it takes a dent out of all the provinces in Canada! This is just the tip of the ICE BURG in Canada. 

Investors here are waiting for that big Contract before diving in. 

I say add up all the little contracts that have transpired so far and you have your big contract.

Little contracts that will swell into bigger contracts.

Contracts that have recurring patients year over year.

Eventually those big contracts will come, with the acceptance of our new technology.

Bullboard Posts